HighTower Advisors
ABMD

HighTower Advisors’s Abiomed Inc ABMD Stock Holding History

HighTower Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100
Closed -$1K – 2453
2018
Q2 		$1K Buy
+100
New +$36.2K ﹤0.01% 2230

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HighTower Advisors's ABMD Position: Q4 2022 in Review

HighTower Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 13,014 shares — an estimated $3.15M sold.

HighTower Advisors first reported a position in ABMD in Q2 2018 and held it in 17 quarters. The position peaked at $4.28M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • HighTower Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • HighTower Advisors sold 13,014 Abiomed Inc shares in Q4 2022, an estimated $3.15M.
  • HighTower Advisors first reported a position in Abiomed Inc in Q2 2018 and held it in 17 quarters.
  • HighTower Advisors's Abiomed Inc position peaked at $4.28M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on HighTower Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.